Literature DB >> 5807154

Antibacterial activity of 2'-esters of erythromycin.

P L Tardrew, J C Mao, D Kenney.   

Abstract

The effect of esterification at the 2'-position of desosamine on the antibacterial activity of erythromycin was investigated by determining the bacteriostatic and bactericidal activities of erythromycin and a number of its 2'-esters on S. aureus and relating these activities to the hydrolysis rates of the esters. These studies, together with comparison of the inhibition of protein synthesis in a cell-free system isolated from S. aureus, lead to the conclusion that 2'-esters of erythromycin are inactive until hydrolyzed. Loss of activity appears to result from inability of erythromycin esters to bind to bacterial ribosomes and thus inhibit synthesis of protein.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5807154      PMCID: PMC377936          DOI: 10.1128/am.18.2.159-165.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  5 in total

1.  EFFECT OF ERYTHROMYCIN ON PROTEIN BIOSYNTHESIS IN BACILLUS SUBTILIS.

Authors:  S B TAUBMAN; A G SO; F E YOUNG; E W DAVIE; J W CORCORAN
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

2.  Interaction of antibiotics with ribosomes: structure-function relationships and a possible common mechanism for the antibacterial action of the macrolides and lincomycin.

Authors:  J M Wilhelm; N L Oleinick; J W Corcoran
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

3.  Mode of action of macrolides.

Authors:  J C Mao; R G Wiegand
Journal:  Biochim Biophys Acta       Date:  1968-04-22

4.  Protein synthesis in a cell-free extract from Staphylococcus aureus.

Authors:  J C Mao
Journal:  J Bacteriol       Date:  1967-07       Impact factor: 3.490

5.  The stoichiometry of erythromycin binding to ribosomal particles of Staphylococcus aureus.

Authors:  J C Mao
Journal:  Biochem Pharmacol       Date:  1967-12       Impact factor: 5.858

  5 in total
  12 in total

Review 1.  New directions for macrolide antibiotics: structural modifications and in vitro activity.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Trade names or approved names. Part III. Special cases. Clinical trials.

Authors:  J C Garnham
Journal:  Postgrad Med J       Date:  1974-02       Impact factor: 2.401

3.  Single-dose fasting bioequivalence assessment of erythromycin stearate tablets in man.

Authors:  G J Yakatan; W J Poynor; R G Harris; A Martin; R G Leonard; A H Briggs; J T Doluisio
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

4.  Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.

Authors:  P Patamasucon; S Kaojarern; H Kusmiesz; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

5.  Plasma and salivary concentrations of erythromycin after administration of three different formulations.

Authors:  J Henry; P Turner; M Garland; F Esmieu
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

6.  Biliary excretion of erythromycin after parenteral administration.

Authors:  P Chelvan; J M Hamilton-Miller; W Brumfitt
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

7.  Catalytic site-selective synthesis and evaluation of a series of erythromycin analogs.

Authors:  Chad A Lewis; Janie Merkel; Scott J Miller
Journal:  Bioorg Med Chem Lett       Date:  2008-09-09       Impact factor: 2.823

8.  Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.

Authors:  D Bérubé; D Kirouac; D Croteau; M G Bergeron; M Lebel
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

9.  Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.

Authors:  D Croteau; M G Bergeron; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

Review 10.  Pharmacokinetic interactions of the macrolide antibiotics.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.